Cardiovascular risk biomarkers and metabolically unhealthy status in prepubertal children: Comparison of definitions

Nutr Metab Cardiovasc Dis. 2018 May;28(5):524-530. doi: 10.1016/j.numecd.2018.02.006. Epub 2018 Feb 16.

Abstract

Background and aims: The early onset of cardio-metabolic abnormalities, known as metabolically unhealthy (MU) status, is highly associated with obesity and cardiovascular disease (CVD), as well as with increased morbidity and mortality later in life. Given the lack of a consensus MU classification for prepubertal children, we aimed to compare available MU definitions in terms of their association with CVD risk biomarkers.

Methods and results: A total of 930 prepubertal children (622 with overweight/obesity, 462 males) aged 5-10.9 years were recruited, anthropometric measures were taken and biomarkers were analyzed. Children were classified using eight MU definitions based on different cut-offs for blood pressure, triacylglycerides, high-density lipoprotein cholesterol, glucose and homeostasis model assessment for insulin resistance (HOMA-IR). MU prevalence in children with overweight/obesity ranged between 30% and 60% across definitions. Plasma concentrations of resistin, leptin, myeloperoxidase (MPO) and total plasminogen activator inhibitor 1 (tPAI-1) were higher, and those of adiponectin were lower, in MU compared to MH children with overweight/obesity. Linear regression analyses confirmed the contribution of MPO and tPAI-1 concentrations to MU status, with most significant results derived from definitions that use age and sex-specific criteria and that account for HOMA-IR.

Conclusion: Plasma concentrations of MPO and tPAI-1 are increased in prepubertal MU children irrespective of having normal-weight or overweight/obesity. Inclusion of age and sex-specific cut-offs for cardio-metabolic components as well as insulin resistance criteria increases the quality of MU definitions as seen by their stronger association with CVD biomarkers concentrations.

Keywords: Cardiovascular disease; Childhood obesity; Insulin resistance; Metabolic health.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Biomarkers / blood
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / classification
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology
  • Child
  • Child, Preschool
  • Female
  • Health Status*
  • Humans
  • Insulin Resistance
  • Male
  • Metabolic Syndrome / blood*
  • Metabolic Syndrome / classification
  • Metabolic Syndrome / diagnosis
  • Metabolic Syndrome / epidemiology
  • Pediatric Obesity / blood*
  • Pediatric Obesity / classification
  • Pediatric Obesity / diagnosis
  • Pediatric Obesity / epidemiology
  • Peroxidase / blood*
  • Plasminogen Activator Inhibitor 1 / blood*
  • Predictive Value of Tests
  • Prevalence
  • Risk Factors
  • Sex Factors
  • Spain / epidemiology
  • Terminology as Topic*

Substances

  • Biomarkers
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • Peroxidase